387 related articles for article (PubMed ID: 30147301)
1. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
2. SUR1-TRPM4 channels, not K
Woo SK; Tsymbalyuk N; Tsymbalyuk O; Ivanova S; Gerzanich V; Simard JM
Neurosci Lett; 2020 Jan; 718():134729. PubMed ID: 31899311
[TBL] [Abstract][Full Text] [Related]
3. SUR1-TRPM4 and AQP4 form a heteromultimeric complex that amplifies ion/water osmotic coupling and drives astrocyte swelling.
Stokum JA; Kwon MS; Woo SK; Tsymbalyuk O; Vennekens R; Gerzanich V; Simard JM
Glia; 2018 Jan; 66(1):108-125. PubMed ID: 28906027
[TBL] [Abstract][Full Text] [Related]
4. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
[TBL] [Abstract][Full Text] [Related]
5. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice.
Wang X; Chang Y; He Y; Lyu C; Li H; Zhu J; Liu K; Hu Y; Huang K; Pan S
Neuropharmacology; 2020 Jan; 162():107845. PubMed ID: 31704276
[TBL] [Abstract][Full Text] [Related]
6. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage.
Jiang B; Li L; Chen Q; Tao Y; Yang L; Zhang B; Zhang JH; Feng H; Chen Z; Tang J; Zhu G
Transl Stroke Res; 2017 Apr; 8(2):183-193. PubMed ID: 27807801
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.
Gerzanich V; Stokum JA; Ivanova S; Woo SK; Tsymbalyuk O; Sharma A; Akkentli F; Imran Z; Aarabi B; Sahuquillo J; Simard JM
J Neurotrauma; 2019 Apr; 36(7):1060-1079. PubMed ID: 30160201
[TBL] [Abstract][Full Text] [Related]
8. BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.
Pergakis M; Badjatia N; Chaturvedi S; Cronin CA; Kimberly WT; Sheth KN; Simard JM
Expert Opin Investig Drugs; 2019 Dec; 28(12):1031-1040. PubMed ID: 31623469
[No Abstract] [Full Text] [Related]
9. Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts.
Mehta RI; Tosun C; Ivanova S; Tsymbalyuk N; Famakin BM; Kwon MS; Castellani RJ; Gerzanich V; Simard JM
J Neuropathol Exp Neurol; 2015 Aug; 74(8):835-49. PubMed ID: 26172285
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.
Wilkinson CM; Brar PS; Balay CJ; Colbourne F
PLoS One; 2019; 14(5):e0215952. PubMed ID: 31042750
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
Caffes N; Kurland DB; Gerzanich V; Simard JM
Int J Mol Sci; 2015 Mar; 16(3):4973-84. PubMed ID: 25749474
[TBL] [Abstract][Full Text] [Related]
12. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
Jha RM; Bell J; Citerio G; Hemphill JC; Kimberly WT; Narayan RK; Sahuquillo J; Sheth KN; Simard JM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936452
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia.
He Y; Chang Y; Peng Y; Zhu J; Liu K; Chen J; Wu Y; Ji Z; Lin Z; Wang S; Gupta S; Zang N; Pan S; Huang K
Mol Neurobiol; 2022 Oct; 59(10):6590-6607. PubMed ID: 35972671
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
Tosun C; Kurland DB; Mehta R; Castellani RJ; deJong JL; Kwon MS; Woo SK; Gerzanich V; Simard JM
Stroke; 2013 Dec; 44(12):3522-8. PubMed ID: 24114458
[TBL] [Abstract][Full Text] [Related]
16. Glibenclamide in cerebral ischemia and stroke.
Simard JM; Sheth KN; Kimberly WT; Stern BJ; del Zoppo GJ; Jacobson S; Gerzanich V
Neurocrit Care; 2014 Apr; 20(2):319-33. PubMed ID: 24132564
[TBL] [Abstract][Full Text] [Related]
17. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
18. Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.
Khanna A; Walcott BP; Kahle KT; Simard JM
Neurosurg Focus; 2014 Jan; 36(1):E11. PubMed ID: 24380477
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus.
Lin Z; Huang H; Gu Y; Huang K; Hu Y; Ji Z; Wu Y; Wang S; Yang T; Pan S
Neuropharmacology; 2017 Jul; 121():1-11. PubMed ID: 28412320
[TBL] [Abstract][Full Text] [Related]
20. Does inhibiting Sur1 complement rt-PA in cerebral ischemia?
Simard JM; Geng Z; Silver FL; Sheth KN; Kimberly WT; Stern BJ; Colucci M; Gerzanich V
Ann N Y Acad Sci; 2012 Sep; 1268():95-107. PubMed ID: 22994227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]